nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofarabine—Nucleic Acid Synthesis Inhibitors—Azathioprine—multiple sclerosis	0.249	1	CiPCiCtD
Clofarabine—Cladribine—multiple sclerosis	0.23	1	CrCtD
Clofarabine—RRM1—multiple sclerosis	0.153	1	CbGaD
Clofarabine—RRM2—Cladribine—multiple sclerosis	0.049	0.272	CbGbCtD
Clofarabine—RRM1—Cladribine—multiple sclerosis	0.049	0.272	CbGbCtD
Clofarabine—POLA1—Cladribine—multiple sclerosis	0.0424	0.235	CbGbCtD
Clofarabine—DCK—Cladribine—multiple sclerosis	0.0261	0.145	CbGbCtD
Clofarabine—Regadenoson—Cladribine—multiple sclerosis	0.021	0.146	CrCrCtD
Clofarabine—Fludarabine—Cladribine—multiple sclerosis	0.0197	0.137	CrCrCtD
Clofarabine—Adenosine monophosphate—Cladribine—multiple sclerosis	0.0185	0.129	CrCrCtD
Clofarabine—Nelarabine—Cladribine—multiple sclerosis	0.0185	0.129	CrCrCtD
Clofarabine—Adenosine—Cladribine—multiple sclerosis	0.0166	0.116	CrCrCtD
Clofarabine—Azacitidine—Cladribine—multiple sclerosis	0.0166	0.116	CrCrCtD
Clofarabine—Vidarabine—Cladribine—multiple sclerosis	0.0166	0.116	CrCrCtD
Clofarabine—Decitabine—Cladribine—multiple sclerosis	0.0159	0.111	CrCrCtD
Clofarabine—ABCG2—Cladribine—multiple sclerosis	0.00556	0.0309	CbGbCtD
Clofarabine—ABCG2—Mitoxantrone—multiple sclerosis	0.00406	0.0225	CbGbCtD
Clofarabine—ABCG2—Dexamethasone—multiple sclerosis	0.0021	0.0117	CbGbCtD
Clofarabine—ABCG2—Methotrexate—multiple sclerosis	0.00169	0.00939	CbGbCtD
Clofarabine—RRM1—Nucleotide Metabolism—SRM—multiple sclerosis	0.00132	0.168	CbGpPWpGaD
Clofarabine—RRM2—Nucleotide Metabolism—SRM—multiple sclerosis	0.00108	0.138	CbGpPWpGaD
Clofarabine—POLA1—Nucleotide Metabolism—SRM—multiple sclerosis	0.000742	0.0944	CbGpPWpGaD
Clofarabine—S-Adenosylmethionine—SRM—multiple sclerosis	0.000669	0.602	CrCbGaD
Clofarabine—RRM2—Synthesis and interconversion of nucleotide di- and triphosphates—RRM1—multiple sclerosis	0.000605	0.077	CbGpPWpGaD
Clofarabine—RRM2—Nucleotide Metabolism—RRM1—multiple sclerosis	0.000579	0.0737	CbGpPWpGaD
Clofarabine—POLA1—Nucleotide Metabolism—RRM1—multiple sclerosis	0.000396	0.0504	CbGpPWpGaD
Clofarabine—RRM2—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.000372	0.0474	CbGpPWpGaD
Clofarabine—POLA1—retina—multiple sclerosis	0.000315	0.0874	CbGeAlD
Clofarabine—Fludarabine—RRM1—multiple sclerosis	0.000277	0.25	CrCbGaD
Clofarabine—RRM1—retina—multiple sclerosis	0.00025	0.0694	CbGeAlD
Clofarabine—RRM2—E2F transcription factor network—RRM1—multiple sclerosis	0.000197	0.0251	CbGpPWpGaD
Clofarabine—DCK—retina—multiple sclerosis	0.000194	0.0539	CbGeAlD
Clofarabine—RRM2—Nucleotide metabolism—RRM1—multiple sclerosis	0.000187	0.0238	CbGpPWpGaD
Clofarabine—RRM1—medulla oblongata—multiple sclerosis	0.000181	0.0502	CbGeAlD
Clofarabine—DCK—Nucleotide metabolism—RRM1—multiple sclerosis	0.000175	0.0223	CbGpPWpGaD
Clofarabine—RRM1—Azacitidine—Cladribine—multiple sclerosis	0.000172	0.248	CbGdCrCtD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—RRM1—multiple sclerosis	0.000172	0.0218	CbGpPWpGaD
Clofarabine—RRM1—midbrain—multiple sclerosis	0.000165	0.0458	CbGeAlD
Clofarabine—Cladribine—RRM1—multiple sclerosis	0.000164	0.148	CrCbGaD
Clofarabine—RRM2—nervous system—multiple sclerosis	0.000163	0.0454	CbGeAlD
Clofarabine—RRM1—spinal cord—multiple sclerosis	0.000161	0.0447	CbGeAlD
Clofarabine—POLA1—cerebellum—multiple sclerosis	0.000161	0.0447	CbGeAlD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—RRM1—multiple sclerosis	0.00016	0.0204	CbGpPWpGaD
Clofarabine—ABCG2—Irinotecan Pathway—BCHE—multiple sclerosis	0.000159	0.0202	CbGpPWpGaD
Clofarabine—RRM2—central nervous system—multiple sclerosis	0.000157	0.0437	CbGeAlD
Clofarabine—DCK—medulla oblongata—multiple sclerosis	0.00014	0.039	CbGeAlD
Clofarabine—ABCG2—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.000139	0.0177	CbGpPWpGaD
Clofarabine—RRM1—nervous system—multiple sclerosis	0.000136	0.0377	CbGeAlD
Clofarabine—POLA1—E2F transcription factor network—RRM1—multiple sclerosis	0.000135	0.0172	CbGpPWpGaD
Clofarabine—POLA1—brain—multiple sclerosis	0.000131	0.0363	CbGeAlD
Clofarabine—RRM1—central nervous system—multiple sclerosis	0.000131	0.0363	CbGeAlD
Clofarabine—DCK—midbrain—multiple sclerosis	0.000128	0.0356	CbGeAlD
Clofarabine—RRM1—cerebellum—multiple sclerosis	0.000128	0.0355	CbGeAlD
Clofarabine—DCK—spinal cord—multiple sclerosis	0.000125	0.0347	CbGeAlD
Clofarabine—RRM2—brain—multiple sclerosis	0.000125	0.0347	CbGeAlD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—RRM1—multiple sclerosis	0.000117	0.0149	CbGpPWpGaD
Clofarabine—RRM2—Azacitidine—Cladribine—multiple sclerosis	0.000108	0.156	CbGdCrCtD
Clofarabine—DCK—nervous system—multiple sclerosis	0.000105	0.0293	CbGeAlD
Clofarabine—RRM1—brain—multiple sclerosis	0.000104	0.0288	CbGeAlD
Clofarabine—DCK—central nervous system—multiple sclerosis	0.000101	0.0282	CbGeAlD
Clofarabine—DCK—cerebellum—multiple sclerosis	9.91e-05	0.0275	CbGeAlD
Clofarabine—DCK—brain—multiple sclerosis	8.05e-05	0.0224	CbGeAlD
Clofarabine—ABCG2—medulla oblongata—multiple sclerosis	7.82e-05	0.0217	CbGeAlD
Clofarabine—ABCG2—midbrain—multiple sclerosis	7.15e-05	0.0199	CbGeAlD
Clofarabine—ABCG2—spinal cord—multiple sclerosis	6.98e-05	0.0194	CbGeAlD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	6.25e-05	0.00796	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	6.08e-05	0.00774	CbGpPWpGaD
Clofarabine—ABCG2—cerebellum—multiple sclerosis	5.53e-05	0.0154	CbGeAlD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	4.88e-05	0.00621	CbGpPWpGaD
Clofarabine—ABCG2—brain—multiple sclerosis	4.49e-05	0.0125	CbGeAlD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	4.18e-05	0.00532	CbGpPWpGaD
Clofarabine—RRM1—E2F transcription factor network—MYC—multiple sclerosis	4.11e-05	0.00523	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—SRM—multiple sclerosis	3.87e-05	0.00492	CbGpPWpGaD
Clofarabine—DCK—Desoximetasone—Methylprednisolone—multiple sclerosis	3.65e-05	0.0527	CbGdCrCtD
Clofarabine—DCK—Desoximetasone—Betamethasone—multiple sclerosis	3.6e-05	0.0519	CbGdCrCtD
Clofarabine—DCK—Desoximetasone—Dexamethasone—multiple sclerosis	3.6e-05	0.0519	CbGdCrCtD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—MYC—multiple sclerosis	3.57e-05	0.00455	CbGpPWpGaD
Clofarabine—DCK—Diflorasone—Methylprednisolone—multiple sclerosis	3.55e-05	0.0512	CbGdCrCtD
Clofarabine—DCK—Desoximetasone—Triamcinolone—multiple sclerosis	3.51e-05	0.0507	CbGdCrCtD
Clofarabine—DCK—Diflorasone—Dexamethasone—multiple sclerosis	3.49e-05	0.0504	CbGdCrCtD
Clofarabine—DCK—Diflorasone—Betamethasone—multiple sclerosis	3.49e-05	0.0504	CbGdCrCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	3.43e-05	0.00436	CbGpPWpGaD
Clofarabine—DCK—Diflorasone—Triamcinolone—multiple sclerosis	3.41e-05	0.0492	CbGdCrCtD
Clofarabine—RRM2—E2F transcription factor network—MYC—multiple sclerosis	3.39e-05	0.00431	CbGpPWpGaD
Clofarabine—DCK—Desoximetasone—Prednisone—multiple sclerosis	3.33e-05	0.0481	CbGdCrCtD
Clofarabine—DCK—Desoximetasone—Prednisolone—multiple sclerosis	3.26e-05	0.047	CbGdCrCtD
Clofarabine—DCK—Diflorasone—Prednisone—multiple sclerosis	3.24e-05	0.0467	CbGdCrCtD
Clofarabine—RRM2—Metabolism—SRM—multiple sclerosis	3.18e-05	0.00405	CbGpPWpGaD
Clofarabine—DCK—Diflorasone—Prednisolone—multiple sclerosis	3.16e-05	0.0456	CbGdCrCtD
Clofarabine—DCK—Metabolism—SRM—multiple sclerosis	2.98e-05	0.00379	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—MYC—multiple sclerosis	2.94e-05	0.00374	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	2.75e-05	0.0035	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—MYC—multiple sclerosis	2.75e-05	0.0035	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CYP27B1—multiple sclerosis	2.72e-05	0.00347	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CYP24A1—multiple sclerosis	2.72e-05	0.00347	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—GPC5—multiple sclerosis	2.49e-05	0.00317	CbGpPWpGaD
Clofarabine—RRM2—G1/S Transition—MYC—multiple sclerosis	2.46e-05	0.00313	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	2.35e-05	0.003	CbGpPWpGaD
Clofarabine—Pain—Mitoxantrone—multiple sclerosis	2.32e-05	0.000749	CcSEcCtD
Clofarabine—POLA1—E2F transcription factor network—MYC—multiple sclerosis	2.32e-05	0.00295	CbGpPWpGaD
Clofarabine—Alopecia—Dexamethasone—multiple sclerosis	2.31e-05	0.000746	CcSEcCtD
Clofarabine—Alopecia—Betamethasone—multiple sclerosis	2.31e-05	0.000746	CcSEcCtD
Clofarabine—Diarrhoea—Azathioprine—multiple sclerosis	2.3e-05	0.000742	CcSEcCtD
Clofarabine—Haemoglobin—Prednisone—multiple sclerosis	2.29e-05	0.000739	CcSEcCtD
Clofarabine—Haemorrhage—Prednisone—multiple sclerosis	2.28e-05	0.000735	CcSEcCtD
Clofarabine—Erythema—Dexamethasone—multiple sclerosis	2.27e-05	0.000735	CcSEcCtD
Clofarabine—Erythema—Betamethasone—multiple sclerosis	2.27e-05	0.000735	CcSEcCtD
Clofarabine—Pancytopenia—Methotrexate—multiple sclerosis	2.26e-05	0.000729	CcSEcCtD
Clofarabine—RRM2—Metabolism—CYP27B1—multiple sclerosis	2.24e-05	0.00285	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CYP24A1—multiple sclerosis	2.24e-05	0.00285	CbGpPWpGaD
Clofarabine—Connective tissue disorder—Prednisone—multiple sclerosis	2.24e-05	0.000723	CcSEcCtD
Clofarabine—Feeling abnormal—Mitoxantrone—multiple sclerosis	2.23e-05	0.000722	CcSEcCtD
Clofarabine—Oedema—Prednisolone—multiple sclerosis	2.23e-05	0.000719	CcSEcCtD
Clofarabine—Neutropenia—Methotrexate—multiple sclerosis	2.22e-05	0.000718	CcSEcCtD
Clofarabine—Dizziness—Azathioprine—multiple sclerosis	2.22e-05	0.000717	CcSEcCtD
Clofarabine—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	2.22e-05	0.000717	CcSEcCtD
Clofarabine—Upper respiratory tract infection—Methotrexate—multiple sclerosis	2.21e-05	0.000714	CcSEcCtD
Clofarabine—Cough—Triamcinolone—multiple sclerosis	2.19e-05	0.000707	CcSEcCtD
Clofarabine—Tachycardia—Prednisolone—multiple sclerosis	2.17e-05	0.000702	CcSEcCtD
Clofarabine—Hypertension—Triamcinolone—multiple sclerosis	2.16e-05	0.000699	CcSEcCtD
Clofarabine—Hypertension—Methylprednisolone—multiple sclerosis	2.16e-05	0.000698	CcSEcCtD
Clofarabine—Hyperhidrosis—Prednisolone—multiple sclerosis	2.15e-05	0.000695	CcSEcCtD
Clofarabine—Body temperature increased—Mitoxantrone—multiple sclerosis	2.14e-05	0.000693	CcSEcCtD
Clofarabine—Abdominal pain—Mitoxantrone—multiple sclerosis	2.14e-05	0.000693	CcSEcCtD
Clofarabine—Myalgia—Triamcinolone—multiple sclerosis	2.13e-05	0.00069	CcSEcCtD
Clofarabine—Vomiting—Azathioprine—multiple sclerosis	2.13e-05	0.000689	CcSEcCtD
Clofarabine—Pneumonia—Methotrexate—multiple sclerosis	2.13e-05	0.000689	CcSEcCtD
Clofarabine—Myalgia—Methylprednisolone—multiple sclerosis	2.13e-05	0.000688	CcSEcCtD
Clofarabine—Arthralgia—Methylprednisolone—multiple sclerosis	2.13e-05	0.000688	CcSEcCtD
Clofarabine—Anxiety—Methylprednisolone—multiple sclerosis	2.12e-05	0.000686	CcSEcCtD
Clofarabine—Infestation NOS—Methotrexate—multiple sclerosis	2.12e-05	0.000685	CcSEcCtD
Clofarabine—Infestation—Methotrexate—multiple sclerosis	2.12e-05	0.000685	CcSEcCtD
Clofarabine—Rash—Azathioprine—multiple sclerosis	2.12e-05	0.000683	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	2.12e-05	0.000683	CcSEcCtD
Clofarabine—Dermatitis—Azathioprine—multiple sclerosis	2.11e-05	0.000683	CcSEcCtD
Clofarabine—Flushing—Prednisone—multiple sclerosis	2.11e-05	0.000682	CcSEcCtD
Clofarabine—Headache—Azathioprine—multiple sclerosis	2.1e-05	0.000679	CcSEcCtD
Clofarabine—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	2.1e-05	0.000679	CcSEcCtD
Clofarabine—DCK—Metabolism—CYP24A1—multiple sclerosis	2.1e-05	0.00267	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CYP27B1—multiple sclerosis	2.1e-05	0.00267	CbGpPWpGaD
Clofarabine—Renal failure—Methotrexate—multiple sclerosis	2.08e-05	0.000673	CcSEcCtD
Clofarabine—RRM2—Mitotic G1-G1/S phases—MYC—multiple sclerosis	2.07e-05	0.00263	CbGpPWpGaD
Clofarabine—Stomatitis—Methotrexate—multiple sclerosis	2.07e-05	0.000667	CcSEcCtD
Clofarabine—Angiopathy—Prednisone—multiple sclerosis	2.06e-05	0.000667	CcSEcCtD
Clofarabine—Immune system disorder—Prednisone—multiple sclerosis	2.06e-05	0.000664	CcSEcCtD
Clofarabine—RRM2—Metabolism—GPC5—multiple sclerosis	2.05e-05	0.00261	CbGpPWpGaD
Clofarabine—Oedema—Triamcinolone—multiple sclerosis	2.05e-05	0.000661	CcSEcCtD
Clofarabine—Infection—Triamcinolone—multiple sclerosis	2.03e-05	0.000657	CcSEcCtD
Clofarabine—Infection—Methylprednisolone—multiple sclerosis	2.03e-05	0.000655	CcSEcCtD
Clofarabine—Haematuria—Methotrexate—multiple sclerosis	2.02e-05	0.000653	CcSEcCtD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—multiple sclerosis	2.01e-05	0.00256	CbGpPWpGaD
Clofarabine—Alopecia—Prednisone—multiple sclerosis	2.01e-05	0.00065	CcSEcCtD
Clofarabine—Hepatobiliary disease—Methotrexate—multiple sclerosis	2e-05	0.000647	CcSEcCtD
Clofarabine—Nervous system disorder—Methylprednisolone—multiple sclerosis	2e-05	0.000647	CcSEcCtD
Clofarabine—Epistaxis—Methotrexate—multiple sclerosis	2e-05	0.000646	CcSEcCtD
Clofarabine—Hypersensitivity—Mitoxantrone—multiple sclerosis	2e-05	0.000646	CcSEcCtD
Clofarabine—Paraesthesia—Prednisolone—multiple sclerosis	2e-05	0.000646	CcSEcCtD
Clofarabine—Tachycardia—Triamcinolone—multiple sclerosis	2e-05	0.000645	CcSEcCtD
Clofarabine—Mental disorder—Prednisone—multiple sclerosis	1.99e-05	0.000644	CcSEcCtD
Clofarabine—Nausea—Azathioprine—multiple sclerosis	1.99e-05	0.000644	CcSEcCtD
Clofarabine—Tachycardia—Methylprednisolone—multiple sclerosis	1.99e-05	0.000644	CcSEcCtD
Clofarabine—Skin disorder—Methylprednisolone—multiple sclerosis	1.98e-05	0.000641	CcSEcCtD
Clofarabine—Erythema—Prednisone—multiple sclerosis	1.98e-05	0.00064	CcSEcCtD
Clofarabine—Malnutrition—Prednisone—multiple sclerosis	1.98e-05	0.00064	CcSEcCtD
Clofarabine—Hyperhidrosis—Triamcinolone—multiple sclerosis	1.98e-05	0.000639	CcSEcCtD
Clofarabine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	1.97e-05	0.000638	CcSEcCtD
Clofarabine—Hypertension—Betamethasone—multiple sclerosis	1.96e-05	0.000635	CcSEcCtD
Clofarabine—Hypertension—Dexamethasone—multiple sclerosis	1.96e-05	0.000635	CcSEcCtD
Clofarabine—Asthenia—Mitoxantrone—multiple sclerosis	1.95e-05	0.000629	CcSEcCtD
Clofarabine—Myalgia—Betamethasone—multiple sclerosis	1.94e-05	0.000626	CcSEcCtD
Clofarabine—Myalgia—Dexamethasone—multiple sclerosis	1.94e-05	0.000626	CcSEcCtD
Clofarabine—Anxiety—Betamethasone—multiple sclerosis	1.93e-05	0.000624	CcSEcCtD
Clofarabine—Anxiety—Dexamethasone—multiple sclerosis	1.93e-05	0.000624	CcSEcCtD
Clofarabine—ABCG2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	1.93e-05	0.00245	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GPC5—multiple sclerosis	1.92e-05	0.00244	CbGpPWpGaD
Clofarabine—Haemoglobin—Methotrexate—multiple sclerosis	1.91e-05	0.000618	CcSEcCtD
Clofarabine—Hypotension—Methylprednisolone—multiple sclerosis	1.91e-05	0.000616	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.9e-05	0.00242	CbGpPWpGaD
Clofarabine—Pain—Prednisolone—multiple sclerosis	1.9e-05	0.000615	CcSEcCtD
Clofarabine—Haemorrhage—Methotrexate—multiple sclerosis	1.9e-05	0.000615	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.9e-05	0.00242	CbGpPWpGaD
Clofarabine—Urinary tract disorder—Methotrexate—multiple sclerosis	1.88e-05	0.000607	CcSEcCtD
Clofarabine—Urethral disorder—Methotrexate—multiple sclerosis	1.86e-05	0.000602	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	1.86e-05	0.000602	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.86e-05	0.00237	CbGpPWpGaD
Clofarabine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	1.86e-05	0.000601	CcSEcCtD
Clofarabine—Oedema—Betamethasone—multiple sclerosis	1.86e-05	0.0006	CcSEcCtD
Clofarabine—Oedema—Dexamethasone—multiple sclerosis	1.86e-05	0.0006	CcSEcCtD
Clofarabine—Diarrhoea—Mitoxantrone—multiple sclerosis	1.86e-05	0.0006	CcSEcCtD
Clofarabine—Infection—Dexamethasone—multiple sclerosis	1.84e-05	0.000596	CcSEcCtD
Clofarabine—Infection—Betamethasone—multiple sclerosis	1.84e-05	0.000596	CcSEcCtD
Clofarabine—Paraesthesia—Triamcinolone—multiple sclerosis	1.84e-05	0.000594	CcSEcCtD
Clofarabine—Feeling abnormal—Prednisolone—multiple sclerosis	1.83e-05	0.000592	CcSEcCtD
Clofarabine—Paraesthesia—Methylprednisolone—multiple sclerosis	1.83e-05	0.000592	CcSEcCtD
Clofarabine—Anaemia—Prednisone—multiple sclerosis	1.83e-05	0.000592	CcSEcCtD
Clofarabine—Dyspnoea—Triamcinolone—multiple sclerosis	1.82e-05	0.000589	CcSEcCtD
Clofarabine—Nervous system disorder—Dexamethasone—multiple sclerosis	1.82e-05	0.000588	CcSEcCtD
Clofarabine—Nervous system disorder—Betamethasone—multiple sclerosis	1.82e-05	0.000588	CcSEcCtD
Clofarabine—Agitation—Prednisone—multiple sclerosis	1.82e-05	0.000588	CcSEcCtD
Clofarabine—Thrombocytopenia—Dexamethasone—multiple sclerosis	1.82e-05	0.000587	CcSEcCtD
Clofarabine—Thrombocytopenia—Betamethasone—multiple sclerosis	1.82e-05	0.000587	CcSEcCtD
Clofarabine—Tachycardia—Betamethasone—multiple sclerosis	1.81e-05	0.000585	CcSEcCtD
Clofarabine—Tachycardia—Dexamethasone—multiple sclerosis	1.81e-05	0.000585	CcSEcCtD
Clofarabine—Erythema multiforme—Methotrexate—multiple sclerosis	1.8e-05	0.000581	CcSEcCtD
Clofarabine—Hyperhidrosis—Betamethasone—multiple sclerosis	1.79e-05	0.00058	CcSEcCtD
Clofarabine—Hyperhidrosis—Dexamethasone—multiple sclerosis	1.79e-05	0.00058	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.77e-05	0.00226	CbGpPWpGaD
Clofarabine—Anorexia—Betamethasone—multiple sclerosis	1.77e-05	0.000572	CcSEcCtD
Clofarabine—Anorexia—Dexamethasone—multiple sclerosis	1.77e-05	0.000572	CcSEcCtD
Clofarabine—Cardiac disorder—Methotrexate—multiple sclerosis	1.77e-05	0.00057	CcSEcCtD
Clofarabine—Fatigue—Triamcinolone—multiple sclerosis	1.76e-05	0.00057	CcSEcCtD
Clofarabine—Fatigue—Methylprednisolone—multiple sclerosis	1.76e-05	0.000569	CcSEcCtD
Clofarabine—Pain—Triamcinolone—multiple sclerosis	1.75e-05	0.000565	CcSEcCtD
Clofarabine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	1.74e-05	0.00222	CbGpPWpGaD
Clofarabine—Hypotension—Betamethasone—multiple sclerosis	1.73e-05	0.000561	CcSEcCtD
Clofarabine—Hypotension—Dexamethasone—multiple sclerosis	1.73e-05	0.000561	CcSEcCtD
Clofarabine—Angiopathy—Methotrexate—multiple sclerosis	1.73e-05	0.000558	CcSEcCtD
Clofarabine—Vomiting—Mitoxantrone—multiple sclerosis	1.72e-05	0.000557	CcSEcCtD
Clofarabine—Immune system disorder—Methotrexate—multiple sclerosis	1.72e-05	0.000555	CcSEcCtD
Clofarabine—Mediastinal disorder—Methotrexate—multiple sclerosis	1.71e-05	0.000554	CcSEcCtD
Clofarabine—Hypertension—Prednisone—multiple sclerosis	1.71e-05	0.000553	CcSEcCtD
Clofarabine—Rash—Mitoxantrone—multiple sclerosis	1.71e-05	0.000553	CcSEcCtD
Clofarabine—Dermatitis—Mitoxantrone—multiple sclerosis	1.71e-05	0.000552	CcSEcCtD
Clofarabine—Chills—Methotrexate—multiple sclerosis	1.71e-05	0.000551	CcSEcCtD
Clofarabine—RRM2—Metabolism—RRM1—multiple sclerosis	1.7e-05	0.00216	CbGpPWpGaD
Clofarabine—Headache—Mitoxantrone—multiple sclerosis	1.7e-05	0.000549	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	1.69e-05	0.000547	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	1.69e-05	0.000547	CcSEcCtD
Clofarabine—Arthralgia—Prednisone—multiple sclerosis	1.69e-05	0.000545	CcSEcCtD
Clofarabine—Myalgia—Prednisone—multiple sclerosis	1.69e-05	0.000545	CcSEcCtD
Clofarabine—Feeling abnormal—Triamcinolone—multiple sclerosis	1.69e-05	0.000545	CcSEcCtD
Clofarabine—Feeling abnormal—Methylprednisolone—multiple sclerosis	1.68e-05	0.000544	CcSEcCtD
Clofarabine—Anxiety—Prednisone—multiple sclerosis	1.68e-05	0.000543	CcSEcCtD
Clofarabine—Alopecia—Methotrexate—multiple sclerosis	1.68e-05	0.000543	CcSEcCtD
Clofarabine—POLA1—G1/S Transition—MYC—multiple sclerosis	1.68e-05	0.00214	CbGpPWpGaD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	1.67e-05	0.000541	CcSEcCtD
Clofarabine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	1.67e-05	0.000539	CcSEcCtD
Clofarabine—Paraesthesia—Betamethasone—multiple sclerosis	1.67e-05	0.000539	CcSEcCtD
Clofarabine—Paraesthesia—Dexamethasone—multiple sclerosis	1.67e-05	0.000539	CcSEcCtD
Clofarabine—Mental disorder—Methotrexate—multiple sclerosis	1.67e-05	0.000538	CcSEcCtD
Clofarabine—Malnutrition—Methotrexate—multiple sclerosis	1.66e-05	0.000535	CcSEcCtD
Clofarabine—Erythema—Methotrexate—multiple sclerosis	1.66e-05	0.000535	CcSEcCtD
Clofarabine—Hypersensitivity—Prednisolone—multiple sclerosis	1.64e-05	0.00053	CcSEcCtD
Clofarabine—Body temperature increased—Triamcinolone—multiple sclerosis	1.62e-05	0.000523	CcSEcCtD
Clofarabine—Oedema—Prednisone—multiple sclerosis	1.62e-05	0.000522	CcSEcCtD
Clofarabine—Abdominal pain—Methylprednisolone—multiple sclerosis	1.61e-05	0.000521	CcSEcCtD
Clofarabine—Decreased appetite—Betamethasone—multiple sclerosis	1.61e-05	0.000521	CcSEcCtD
Clofarabine—Decreased appetite—Dexamethasone—multiple sclerosis	1.61e-05	0.000521	CcSEcCtD
Clofarabine—Nausea—Mitoxantrone—multiple sclerosis	1.61e-05	0.000521	CcSEcCtD
Clofarabine—Infection—Prednisone—multiple sclerosis	1.61e-05	0.000519	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	1.6e-05	0.000518	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	1.6e-05	0.000518	CcSEcCtD
Clofarabine—Back pain—Methotrexate—multiple sclerosis	1.6e-05	0.000517	CcSEcCtD
Clofarabine—Fatigue—Dexamethasone—multiple sclerosis	1.6e-05	0.000517	CcSEcCtD
Clofarabine—Fatigue—Betamethasone—multiple sclerosis	1.6e-05	0.000517	CcSEcCtD
Clofarabine—DCK—Metabolism—RRM1—multiple sclerosis	1.59e-05	0.00202	CbGpPWpGaD
Clofarabine—Pain—Betamethasone—multiple sclerosis	1.59e-05	0.000513	CcSEcCtD
Clofarabine—Pain—Dexamethasone—multiple sclerosis	1.59e-05	0.000513	CcSEcCtD
Clofarabine—Nervous system disorder—Prednisone—multiple sclerosis	1.59e-05	0.000512	CcSEcCtD
Clofarabine—Tachycardia—Prednisone—multiple sclerosis	1.58e-05	0.00051	CcSEcCtD
Clofarabine—Skin disorder—Prednisone—multiple sclerosis	1.57e-05	0.000507	CcSEcCtD
Clofarabine—Hyperhidrosis—Prednisone—multiple sclerosis	1.56e-05	0.000505	CcSEcCtD
Clofarabine—Anorexia—Prednisone—multiple sclerosis	1.54e-05	0.000498	CcSEcCtD
Clofarabine—Anaemia—Methotrexate—multiple sclerosis	1.53e-05	0.000494	CcSEcCtD
Clofarabine—Feeling abnormal—Dexamethasone—multiple sclerosis	1.53e-05	0.000494	CcSEcCtD
Clofarabine—Feeling abnormal—Betamethasone—multiple sclerosis	1.53e-05	0.000494	CcSEcCtD
Clofarabine—POLA1—S Phase—MYC—multiple sclerosis	1.53e-05	0.00194	CbGpPWpGaD
Clofarabine—Gastrointestinal pain—Betamethasone—multiple sclerosis	1.52e-05	0.000491	CcSEcCtD
Clofarabine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	1.52e-05	0.000491	CcSEcCtD
Clofarabine—Hypersensitivity—Triamcinolone—multiple sclerosis	1.51e-05	0.000487	CcSEcCtD
Clofarabine—Hypersensitivity—Methylprednisolone—multiple sclerosis	1.5e-05	0.000486	CcSEcCtD
Clofarabine—Leukopenia—Methotrexate—multiple sclerosis	1.48e-05	0.000479	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	1.47e-05	0.000476	CcSEcCtD
Clofarabine—Dizziness—Prednisolone—multiple sclerosis	1.47e-05	0.000475	CcSEcCtD
Clofarabine—Asthenia—Triamcinolone—multiple sclerosis	1.47e-05	0.000474	CcSEcCtD
Clofarabine—Abdominal pain—Betamethasone—multiple sclerosis	1.47e-05	0.000474	CcSEcCtD
Clofarabine—Abdominal pain—Dexamethasone—multiple sclerosis	1.47e-05	0.000474	CcSEcCtD
Clofarabine—Body temperature increased—Betamethasone—multiple sclerosis	1.47e-05	0.000474	CcSEcCtD
Clofarabine—Body temperature increased—Dexamethasone—multiple sclerosis	1.47e-05	0.000474	CcSEcCtD
Clofarabine—Asthenia—Methylprednisolone—multiple sclerosis	1.46e-05	0.000473	CcSEcCtD
Clofarabine—ABCG2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.46e-05	0.00186	CbGpPWpGaD
Clofarabine—Paraesthesia—Prednisone—multiple sclerosis	1.45e-05	0.000469	CcSEcCtD
Clofarabine—Pruritus—Triamcinolone—multiple sclerosis	1.45e-05	0.000468	CcSEcCtD
Clofarabine—Cough—Methotrexate—multiple sclerosis	1.44e-05	0.000467	CcSEcCtD
Clofarabine—Pruritus—Methylprednisolone—multiple sclerosis	1.44e-05	0.000467	CcSEcCtD
Clofarabine—POLA1—Mitotic G1-G1/S phases—MYC—multiple sclerosis	1.42e-05	0.0018	CbGpPWpGaD
Clofarabine—Myalgia—Methotrexate—multiple sclerosis	1.41e-05	0.000455	CcSEcCtD
Clofarabine—Arthralgia—Methotrexate—multiple sclerosis	1.41e-05	0.000455	CcSEcCtD
Clofarabine—Decreased appetite—Prednisone—multiple sclerosis	1.41e-05	0.000454	CcSEcCtD
Clofarabine—Rash—Prednisolone—multiple sclerosis	1.4e-05	0.000453	CcSEcCtD
Clofarabine—Dermatitis—Prednisolone—multiple sclerosis	1.4e-05	0.000453	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	1.4e-05	0.000452	CcSEcCtD
Clofarabine—Diarrhoea—Methylprednisolone—multiple sclerosis	1.4e-05	0.000451	CcSEcCtD
Clofarabine—Fatigue—Prednisone—multiple sclerosis	1.39e-05	0.00045	CcSEcCtD
Clofarabine—Headache—Prednisolone—multiple sclerosis	1.39e-05	0.00045	CcSEcCtD
Clofarabine—Dizziness—Triamcinolone—multiple sclerosis	1.35e-05	0.000437	CcSEcCtD
Clofarabine—Dizziness—Methylprednisolone—multiple sclerosis	1.35e-05	0.000436	CcSEcCtD
Clofarabine—Infection—Methotrexate—multiple sclerosis	1.34e-05	0.000434	CcSEcCtD
Clofarabine—Feeling abnormal—Prednisone—multiple sclerosis	1.33e-05	0.000431	CcSEcCtD
Clofarabine—Asthenia—Betamethasone—multiple sclerosis	1.33e-05	0.00043	CcSEcCtD
Clofarabine—Asthenia—Dexamethasone—multiple sclerosis	1.33e-05	0.00043	CcSEcCtD
Clofarabine—Nervous system disorder—Methotrexate—multiple sclerosis	1.33e-05	0.000428	CcSEcCtD
Clofarabine—Thrombocytopenia—Methotrexate—multiple sclerosis	1.32e-05	0.000427	CcSEcCtD
Clofarabine—Gastrointestinal pain—Prednisone—multiple sclerosis	1.32e-05	0.000427	CcSEcCtD
Clofarabine—Nausea—Prednisolone—multiple sclerosis	1.32e-05	0.000427	CcSEcCtD
Clofarabine—Pruritus—Betamethasone—multiple sclerosis	1.31e-05	0.000424	CcSEcCtD
Clofarabine—Pruritus—Dexamethasone—multiple sclerosis	1.31e-05	0.000424	CcSEcCtD
Clofarabine—Skin disorder—Methotrexate—multiple sclerosis	1.31e-05	0.000424	CcSEcCtD
Clofarabine—Hyperhidrosis—Methotrexate—multiple sclerosis	1.31e-05	0.000422	CcSEcCtD
Clofarabine—Vomiting—Triamcinolone—multiple sclerosis	1.3e-05	0.00042	CcSEcCtD
Clofarabine—Vomiting—Methylprednisolone—multiple sclerosis	1.3e-05	0.000419	CcSEcCtD
Clofarabine—Rash—Triamcinolone—multiple sclerosis	1.29e-05	0.000417	CcSEcCtD
Clofarabine—Dermatitis—Triamcinolone—multiple sclerosis	1.29e-05	0.000416	CcSEcCtD
Clofarabine—Anorexia—Methotrexate—multiple sclerosis	1.29e-05	0.000416	CcSEcCtD
Clofarabine—Rash—Methylprednisolone—multiple sclerosis	1.29e-05	0.000416	CcSEcCtD
Clofarabine—Dermatitis—Methylprednisolone—multiple sclerosis	1.29e-05	0.000416	CcSEcCtD
Clofarabine—Headache—Triamcinolone—multiple sclerosis	1.28e-05	0.000414	CcSEcCtD
Clofarabine—Headache—Methylprednisolone—multiple sclerosis	1.28e-05	0.000413	CcSEcCtD
Clofarabine—Body temperature increased—Prednisone—multiple sclerosis	1.28e-05	0.000413	CcSEcCtD
Clofarabine—Abdominal pain—Prednisone—multiple sclerosis	1.28e-05	0.000413	CcSEcCtD
Clofarabine—Diarrhoea—Dexamethasone—multiple sclerosis	1.27e-05	0.00041	CcSEcCtD
Clofarabine—Diarrhoea—Betamethasone—multiple sclerosis	1.27e-05	0.00041	CcSEcCtD
Clofarabine—Hypotension—Methotrexate—multiple sclerosis	1.26e-05	0.000408	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	1.23e-05	0.000398	CcSEcCtD
Clofarabine—Dizziness—Betamethasone—multiple sclerosis	1.23e-05	0.000397	CcSEcCtD
Clofarabine—Dizziness—Dexamethasone—multiple sclerosis	1.23e-05	0.000397	CcSEcCtD
Clofarabine—Nausea—Triamcinolone—multiple sclerosis	1.22e-05	0.000393	CcSEcCtD
Clofarabine—Paraesthesia—Methotrexate—multiple sclerosis	1.21e-05	0.000392	CcSEcCtD
Clofarabine—Nausea—Methylprednisolone—multiple sclerosis	1.21e-05	0.000392	CcSEcCtD
Clofarabine—Dyspnoea—Methotrexate—multiple sclerosis	1.2e-05	0.000389	CcSEcCtD
Clofarabine—Somnolence—Methotrexate—multiple sclerosis	1.2e-05	0.000388	CcSEcCtD
Clofarabine—Hypersensitivity—Prednisone—multiple sclerosis	1.19e-05	0.000385	CcSEcCtD
Clofarabine—ABCG2—Metabolism—SRM—multiple sclerosis	1.19e-05	0.00152	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—BCHE—multiple sclerosis	1.19e-05	0.00151	CbGpPWpGaD
Clofarabine—Vomiting—Betamethasone—multiple sclerosis	1.18e-05	0.000381	CcSEcCtD
Clofarabine—Vomiting—Dexamethasone—multiple sclerosis	1.18e-05	0.000381	CcSEcCtD
Clofarabine—Decreased appetite—Methotrexate—multiple sclerosis	1.17e-05	0.00038	CcSEcCtD
Clofarabine—Rash—Dexamethasone—multiple sclerosis	1.17e-05	0.000378	CcSEcCtD
Clofarabine—Rash—Betamethasone—multiple sclerosis	1.17e-05	0.000378	CcSEcCtD
Clofarabine—Dermatitis—Dexamethasone—multiple sclerosis	1.17e-05	0.000378	CcSEcCtD
Clofarabine—Dermatitis—Betamethasone—multiple sclerosis	1.17e-05	0.000378	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	1.17e-05	0.000377	CcSEcCtD
Clofarabine—Fatigue—Methotrexate—multiple sclerosis	1.16e-05	0.000376	CcSEcCtD
Clofarabine—Headache—Betamethasone—multiple sclerosis	1.16e-05	0.000376	CcSEcCtD
Clofarabine—Headache—Dexamethasone—multiple sclerosis	1.16e-05	0.000376	CcSEcCtD
Clofarabine—Asthenia—Prednisone—multiple sclerosis	1.16e-05	0.000375	CcSEcCtD
Clofarabine—Pain—Methotrexate—multiple sclerosis	1.16e-05	0.000373	CcSEcCtD
Clofarabine—ABCG2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.15e-05	0.00147	CbGpPWpGaD
Clofarabine—Pruritus—Prednisone—multiple sclerosis	1.14e-05	0.00037	CcSEcCtD
Clofarabine—Feeling abnormal—Methotrexate—multiple sclerosis	1.11e-05	0.00036	CcSEcCtD
Clofarabine—Diarrhoea—Prednisone—multiple sclerosis	1.11e-05	0.000357	CcSEcCtD
Clofarabine—Gastrointestinal pain—Methotrexate—multiple sclerosis	1.1e-05	0.000357	CcSEcCtD
Clofarabine—Nausea—Betamethasone—multiple sclerosis	1.1e-05	0.000356	CcSEcCtD
Clofarabine—Nausea—Dexamethasone—multiple sclerosis	1.1e-05	0.000356	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.07e-05	0.00137	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.07e-05	0.00136	CbGpPWpGaD
Clofarabine—Dizziness—Prednisone—multiple sclerosis	1.07e-05	0.000345	CcSEcCtD
Clofarabine—Body temperature increased—Methotrexate—multiple sclerosis	1.07e-05	0.000345	CcSEcCtD
Clofarabine—Abdominal pain—Methotrexate—multiple sclerosis	1.07e-05	0.000345	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.05e-05	0.00134	CbGpPWpGaD
Clofarabine—Vomiting—Prednisone—multiple sclerosis	1.03e-05	0.000332	CcSEcCtD
Clofarabine—ABCG2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.02e-05	0.0013	CbGpPWpGaD
Clofarabine—Rash—Prednisone—multiple sclerosis	1.02e-05	0.000329	CcSEcCtD
Clofarabine—Dermatitis—Prednisone—multiple sclerosis	1.02e-05	0.000329	CcSEcCtD
Clofarabine—Headache—Prednisone—multiple sclerosis	1.01e-05	0.000327	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	9.99e-06	0.00127	CbGpPWpGaD
Clofarabine—Hypersensitivity—Methotrexate—multiple sclerosis	9.96e-06	0.000322	CcSEcCtD
Clofarabine—RRM2—Metabolism—BCHE—multiple sclerosis	9.76e-06	0.00124	CbGpPWpGaD
Clofarabine—Asthenia—Methotrexate—multiple sclerosis	9.69e-06	0.000313	CcSEcCtD
Clofarabine—Nausea—Prednisone—multiple sclerosis	9.6e-06	0.00031	CcSEcCtD
Clofarabine—Pruritus—Methotrexate—multiple sclerosis	9.56e-06	0.000309	CcSEcCtD
Clofarabine—Diarrhoea—Methotrexate—multiple sclerosis	9.25e-06	0.000299	CcSEcCtD
Clofarabine—DCK—Metabolism—BCHE—multiple sclerosis	9.13e-06	0.00116	CbGpPWpGaD
Clofarabine—Dizziness—Methotrexate—multiple sclerosis	8.94e-06	0.000289	CcSEcCtD
Clofarabine—Vomiting—Methotrexate—multiple sclerosis	8.59e-06	0.000278	CcSEcCtD
Clofarabine—Rash—Methotrexate—multiple sclerosis	8.52e-06	0.000275	CcSEcCtD
Clofarabine—Dermatitis—Methotrexate—multiple sclerosis	8.51e-06	0.000275	CcSEcCtD
Clofarabine—Headache—Methotrexate—multiple sclerosis	8.47e-06	0.000274	CcSEcCtD
Clofarabine—ABCG2—Metabolism—CYP27B1—multiple sclerosis	8.39e-06	0.00107	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP24A1—multiple sclerosis	8.39e-06	0.00107	CbGpPWpGaD
Clofarabine—Nausea—Methotrexate—multiple sclerosis	8.03e-06	0.000259	CcSEcCtD
Clofarabine—ABCG2—Metabolism—GPC5—multiple sclerosis	7.67e-06	0.000976	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—MYC—multiple sclerosis	7.59e-06	0.000966	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	7.43e-06	0.000945	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—APOE—multiple sclerosis	7.13e-06	0.000908	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—MAPK1—multiple sclerosis	6.79e-06	0.000864	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—MYC—multiple sclerosis	6.79e-06	0.000864	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—MAPK1—multiple sclerosis	6.64e-06	0.000845	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—RRM1—multiple sclerosis	6.36e-06	0.000809	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—POMC—multiple sclerosis	6.13e-06	0.00078	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—APOE—multiple sclerosis	5.87e-06	0.000747	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—ALB—multiple sclerosis	5.59e-06	0.000711	CbGpPWpGaD
Clofarabine—DCK—Metabolism—APOE—multiple sclerosis	5.49e-06	0.000698	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—MYC—multiple sclerosis	5.19e-06	0.000661	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	5.08e-06	0.000647	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—POMC—multiple sclerosis	5.05e-06	0.000642	CbGpPWpGaD
Clofarabine—DCK—Metabolism—POMC—multiple sclerosis	4.72e-06	0.0006	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—MYC—multiple sclerosis	4.64e-06	0.000591	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ALB—multiple sclerosis	4.6e-06	0.000585	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—MAPK1—multiple sclerosis	4.54e-06	0.000578	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ALB—multiple sclerosis	4.3e-06	0.000547	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.67e-06	0.000467	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—BCHE—multiple sclerosis	3.65e-06	0.000465	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—APOE—multiple sclerosis	2.2e-06	0.00028	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—POMC—multiple sclerosis	1.89e-06	0.00024	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ALB—multiple sclerosis	1.72e-06	0.000219	CbGpPWpGaD
